Industry heavily investing in mRNA vaccine trials

Industry heavily investing in mRNA vaccine trials

mRNA vaccine trials initiated as a percentage of total vaccine trials initiated each year, sorted by sponsor type

Industry sponsored

Institution/government sponsored

Investigator sponsored

0.50%

0.00%

0.00%

0.70%

0.23%

0.23%

1.47%

0.24%

0.00%

1.46%

0.97%

0.49%

0.43%

0.86%

0.22%

2.59%

0.65%

0.43%

4.24%

2.94%

0.49%

8.90%

16.58%

0.72%

17.13%

6.60%

0.84%

20.00%

3.45%

0.00%

GlobalData